Xwell (XWEL) Research & Development (2010 - 2023)

Xwell (XWEL) posted Research & Development of $273000.0 for Q3 2023, up 33.82% sequentially from $204000.0 in Q2 2023, and down 63.16% YoY from $741000.0 in Q3 2022.

Xwell (XWEL) Research & Development (2010 - 2023) Analysis & Trends

Xwell (XWEL) has 9 years of Research & Development data on file, last reported at $273000.0 in Q3 2023.

  • Quarterly Research & Development fell 63.16% year-over-year to $273000.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $2.1 million (down 74.83% YoY) and the FY2014 annual result came in at $889000.0, down 41.2% from the prior year.
  • Research & Development improved to $273000.0 in Q3 2023 per XWEL's latest filing, from $204000.0 in the prior quarter.
  • The five-year high for Research & Development was $839000.0 in Q2 2022, with the low at $204000.0 in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Waters 31,055.11 Bn 31,054.65 Bn 1.11 Bn 96.00 Mn
2 Thermo Fisher Scientific 191.02 Bn 187.77 Bn 7.74 Bn 336.00 Mn
3 Danaher 137.16 Bn 131.47 Bn 3.59 Bn 387.00 Mn
4 Idexx Laboratories 42.82 Bn 42.62 Bn 722.74 Mn 65.79 Mn
5 Natera 39.09 Bn 37.99 Bn 696.04 Mn 210.70 Mn
6 Agilent Technologies 37.61 Bn 35.81 Bn 990.00 Mn 126.00 Mn
7 Iqvia Holdings 34.23 Bn 32.25 Bn 1.36 Bn -
8 Illumina 28.14 Bn 26.98 Bn 721.00 Mn 240.00 Mn
9 Mettler Toledo International 26.40 Bn 26.33 Bn 555.82 Mn 51.28 Mn
10 Xwell 7.84 Mn 721,916.46 2.35 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2023 273,000.00
Jun 30, 2023 204,000.00
Sep 30, 2022 741,000.00
Jun 30, 2022 839,000.00
Sep 30, 2017 3.90 Mn
Jun 30, 2017 2.69 Mn
Mar 31, 2017 2.96 Mn
Sep 30, 2016 1.55 Mn
Jun 30, 2016 2.18 Mn
Mar 31, 2016 1.13 Mn
Dec 31, 2014 219,000.00
Sep 30, 2014 228,000.00
Jun 30, 2014 217,000.00
Mar 31, 2014 225,000.00
Dec 31, 2013 233,000.00
Sep 30, 2013 542,000.00
Jun 30, 2013 467,000.00
Mar 31, 2013 270,000.00
Dec 31, 2012 -454,000.00
Sep 30, 2012 997,000.00